Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Top Stock Reports for Microsoft, UnitedHealth & Schwab

Published 01/07/2022, 01:08 AM
Updated 07/09/2023, 06:31 AM

Friday, January 7, 2022

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (NASDAQ:MSFT) (MSFT), UnitedHealth Group Incorporated (NYSE:UNH) (UNH), and The Charles Schwab Corporation (NYSE:SCHW) (SCHW). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Shares of Microsoft have outperformed the S&P 500 over the past year (+44.1% vs. +24.9%), with the company benefiting from strength in its Azure cloud platform as well as an accelerated global digital transformation.

Continuation of remote work and mainstream adoption of the hybrid working model has been boosting Teams’ user growth. Microsoft has also been witnessing a surge in user base of its different applications including Microsoft 365 suite, Dynamics and Power Platform. Supply chain disruptions, increasing costs due to Azure enhancements and stiff competition in the cloud space are likely to dent margins, though.

(You can read the full research report on Microsoft here >>>)

UnitedHealth shares have gained +15.3% over the past three months against the Zacks Medical Insurance industry’s gain of +13.2%. The Zacks analyst believes that UnitedHealth has been witnessing strong growth across its Optum and UnitedHealthcare segments, which have, in turn, been driving revenues.

This momentum is likely to continue, in the quarters ahead, on the back of a strong market position, new deals, renewed agreements and expansion of service offerings. UNH's government business also remains well-poised for growth. The international business is expected to bounce back in terms of membership figures. Softness in commercial business due to the ongoing pandemic and rising operating expenses remain as major concerns, though.

(You can read the full research report on UnitedHealth here >>>)

Shares of Schwab have gained +33.8% in the last six months against the Zacks Investment Banking industry’s gain of +11.4%. The Zacks analyst believes that Schwab’s inorganic growth efforts and initiatives to augment trading revenues will keep boosting profitability.

Strategic acquisitions have not only established Schwab as a leading brokerage player, but will also be accretive to earnings. Offering commission-free trading has also led to a rise in client assets and brokerage accounts, thereby improving trading revenues. Lingering near-zero interest rates, with no chance of a hike in the near term and persistently increasing operating expenses, however, are some of the major headwinds.

(You can read the full research report on Schwab here >>>)

Other noteworthy reports we are featuring today include NVIDIA Corporation (NASDAQ:NVDA) (NVDA), Citigroup Inc (NYSE:C). (C) and Diageo (LON:DGE) plc (DEO).

Sheraz Mian

Director of Research

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>


Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

As one investor put it, “curing and preventing hundreds of diseases…what should that market be worth?” This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer (NYSE:SAM) Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Citigroup Inc. (C): Free Stock Analysis Report

Microsoft Corporation (MSFT): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

The Charles Schwab Corporation (SCHW): Free Stock Analysis Report

NVIDIA Corporation (NVDA): Free Stock Analysis Report

Diageo plc (DEO): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.